H, N., M, A., ML, K., M, T., M, B., RM, A., . . . S, L. (2007). Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood, 109(11), 4930. https://doi.org/10.1182/blood-2006-09-047068
Chicago Style (17th ed.) CitationH, Nyman, Adde M, Karjalainen-Lindsberg ML, Taskinen M, Berglund M, Amini RM, Blomqvist C, Enblad G, and Leppä S. "Prognostic Impact of Immunohistochemically Defined Germinal Center Phenotype in Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy." Blood 109, no. 11 (2007): 4930. https://doi.org/10.1182/blood-2006-09-047068.
MLA (9th ed.) CitationH, Nyman, et al. "Prognostic Impact of Immunohistochemically Defined Germinal Center Phenotype in Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy." Blood, vol. 109, no. 11, 2007, p. 4930, https://doi.org/10.1182/blood-2006-09-047068.